Insulin Resistance Scholarly Journal
Insulin resistance is once
cells in your muscles, fat, and liver do not respond well to endocrine and cannot use
aldohexose from your blood for energy. To form up for it, your duct gland makes a lot of endocrine. Over time, your glucose levels go up. Insulin resistance is once
cells in your muscles, fat, and liver don’t respond well to endocrine and can’t simply take up
aldohexose from your blood. As a result, your duct gland makes a lot of endocrine to assist
aldohexose enter your cells. As long as your duct gland will create enough endocrine to beat your cells’ weak response to endocrine, your glucose levels can keep within the healthy vary.
High Impact List of Articles
-
Possibility of switching from liraglutide to oral hypoglycemic agents as a useful therapeutic option for obese Japanese type 2 diabetics
Masanori Iwanishi*, Choka Azuma, Yuji Tezuka, Yukako Yamamoto, Jun Ito-Kobayashi & Miki Washiyama
Case Report: Diabetes Management
-
Possibility of switching from liraglutide to oral hypoglycemic agents as a useful therapeutic option for obese Japanese type 2 diabetics
Masanori Iwanishi*, Choka Azuma, Yuji Tezuka, Yukako Yamamoto, Jun Ito-Kobayashi & Miki Washiyama
Case Report: Diabetes Management
-
Results of angiographic research of coronary vessels in patients with type 2 diabetes mellitus and myocardial infarction
Shatokhina I.V
Research Article: Diabetes Management
-
Results of angiographic research of coronary vessels in patients with type 2 diabetes mellitus and myocardial infarction
Shatokhina I.V
Research Article: Diabetes Management
-
Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus
Nina J Karlin, Meng-Ru Cheng, Janna C Castro & Curtiss B Cook
Research Article: Diabetes Management
-
Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus
Nina J Karlin, Meng-Ru Cheng, Janna C Castro & Curtiss B Cook
Research Article: Diabetes Management
-
The collateral benefits of noninsulin therapies for Type 2 diabetes
Erin D Roe, Natalie C Pon, Priscilla Hollander & Philip Raskin
Review Article: Diabetes Management
-
The collateral benefits of noninsulin therapies for Type 2 diabetes
Erin D Roe, Natalie C Pon, Priscilla Hollander & Philip Raskin
Review Article: Diabetes Management
-
News
News and Views: Diabetes Management
-
News
News and Views: Diabetes Management
Relevant Topics in Clinical